Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djavan, B.
Right arrow Articles by Marberger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djavan, B.
Right arrow Articles by Marberger, M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Prostate Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 20, Issue 4 (February), 2002: 921-929
© 2002 American Society for Clinical Oncology

Novel Artificial Neural Network for Early Detection of Prostate Cancer

By Bob Djavan, Mesut Remzi, Alexandre Zlotta, Christian Seitz, Peter Snow, Michael Marberger

From the Department of Urology, University of Vienna, Austria; Department of Urology, Erasme University Clinics of Brussels, Belgium; and Xaim, Inc, Colorado Springs, CO.

Address reprint requests to Bob Djavan, MD, PhD, Department of Urology, University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; email: bdjavan{at}hotmail.com

PURPOSE: Two artificial neural networks (ANN) for the early detection of prostate cancer in men with total prostate-specific antigen (PSA) levels from 2.5 to 4 ng/mL and from 4 to 10 ng/mL were prospectively developed. The predictive accuracy of the ANN was compared with that obtained by use of conventional statistical analysis of standard PSA parameters.

PATIENTS AND METHODS: Consecutive men with a serum total PSA level between 4 and 10 ng/mL (n = 974) and between 2.5 and 4 ng/mL (n = 272) were analyzed. A separate ANN model was developed for each group of patients. Analyses were performed to determine the presence of prostate cancer.

RESULTS: The area under the receiver operator characteristic (ROC) curve (AUC) was 87.6% and 91.3% for the 2.5 to 4 ng/mL and 4 to 10 ng/mL ANN models, respectively. For the latter model, the AUC generated by the ANN was significantly higher than that produced by the single variables of total PSA, percentage of free PSA, PSA density of the transition zone (TZ), and TZ volume (P < .01), but not significantly higher compared with multivariate analysis. For the 2.5 to 4 ng/mL model, the AUC of the ANN ROC curve was significantly higher than the AUCs for percentage of free PSA (P = .0239), PSA-TZ (P = .0204), and PSA density and total prostate volume (P < .01 for both).

CONCLUSION: The predictive accuracy of the ANN was superior to that of conventional PSA parameters. ANN models might change the way patients referred for early prostate cancer detection are counseled regarding the need for prostate biopsy.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Anticancer ResHome page
C. STEPHAN, H. RITTENHOUSE, H. CAMMANN, M. LEIN, M. SCHRADER, S. DEGER, K. MILLER, and K. JUNG
New Markers and Multivariate Models for Prostate Cancer Detection
Anticancer Res, July 1, 2009; 29(7): 2589 - 2600.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H. J. Lee, K. G. Kim, S. E. Lee, S.-S. Byun, S. I. Hwang, S. I. Jung, S. K. Hong, and S. H. Kim
Role of transrectal ultrasonography in the prediction of prostate cancer: artificial neural network analysis.
J. Ultrasound Med., July 1, 2006; 25(7): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Garzotto, T. M. Beer, R. G. Hudson, L. Peters, Y.-C. Hsieh, E. Barrera, T. Klein, and M. Mori
Improved Detection of Prostate Cancer Using Classification and Regression Tree Analysis
J. Clin. Oncol., July 1, 2005; 23(19): 4322 - 4329.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Y. Matsui, N. Utsunomiya, K. Ichioka, N. Ueda, K. Yoshimura, A. Terai, and Y. Arai
The Use of Artificial Neural Network Analysis to Improve the Predictive Accuracy of Prostate Biopsy in the Japanese Population
Jpn. J. Clin. Oncol., October 1, 2004; 34(10): 602 - 607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Stephan, H. Cammann, A. Semjonow, E. P. Diamandis, L. F.A. Wymenga, M. Lein, P. Sinha, S. A. Loening, and K. Jung
Multicenter Evaluation of an Artificial Neural Network to Increase the Prostate Cancer Detection Rate and Reduce Unnecessary Biopsies
Clin. Chem., August 1, 2002; 48(8): 1279 - 1287.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Kattan
Statistical Prediction Models, Artificial Neural Networks, and the Sophism "I Am a Patient, Not a Statistic"
J. Clin. Oncol., February 15, 2002; 20(4): 885 - 887.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online